Somatostatin receptor scintigraphy with 111In-pentetreotide in patients with the neuroendocrine gastroenteropancreatic tumors
2008
Abstract
To present a few case reports about somatostatin receptor scintigraphy with 111In-pentetreotide in patients with the neuroendocrine gastroenteropancreatic tumors. The early assessment of diagnosis and the accurate staging of the benign and malign neuroendocrine gastroenteropancreatic tumors improve prognosis and determine the way of treatment of patient.